Andrew Mackie

Andrew Mackie is currently the Chief Business Officer at Imcyse SA, a clinical stage biopharmaceutical company. Prior to this role, Andrew served as the Chief Business Officer at Ergomed plc, where Andrew managed corporate acquisitions and product partnerships. With a background in research and development, Andrew has also worked at Eli Lilly, IP Group, Antisoma, and sanofi-aventis in various roles related to clinical development and alliance management. Andrew holds a MBA from London Business School, a LLB in Law from the University of London, and a BSc in Biochemistry from Queen's University in Canada.